Rexnord Corp (RXN) Fundamental Analysis & Valuation

NYSE:RXN

64.95
+0.58 (+0.9%)
At close: Oct 4, 2021
64.95
0 (0%)
After Hours: 10/4/2021, 8:17:32 PM

This RXN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for RXN not available.

RXN Fundamentals: All Metrics, Ratios and Statistics

Rexnord Corp

NYSE:RXN (10/4/2021, 8:17:32 PM)

After market: 64.95 0 (0%)

64.95

+0.58 (+0.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners0.8%
Ins Owner Change0%
Market Cap7.87B
Revenue(TTM)1.59B
Net Income(TTM)180.10M
Analysts90
Price Target71.2 (9.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP12.66%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 44.79
Fwd PE 26.14
P/S 4.95
P/FCF N/A
P/OCF N/A
P/B 4.95
P/tB N/A
EV/EBITDA 20.49
EPS(TTM)1.45
EY2.23%
EPS(NY)2.48
Fwd EY3.83%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.11
BVpS13.11
TBVpSN/A
PEG (NY)2.56
PEG (5Y)3.55
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5%
ROE 11.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 21.05%
PM (TTM) 11.34%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.99
Quick Ratio 2.05
Altman-Z 3.29
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)417.86%
EPS 3Y31.34%
EPS 5Y12.63%
EPS Q2Q%103.45%
EPS Next Y17.51%
EPS Next 2Y18.13%
EPS Next 3Y16.33%
EPS Next 5Y15.87%
Revenue 1Y (TTM)-20.96%
Revenue growth 3Y6.49%
Revenue growth 5Y0.18%
Sales Q2Q%26.54%
Revenue Next Year13.56%
Revenue Next 2Y10%
Revenue Next 3Y8.17%
Revenue Next 5Y6.91%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Rexnord Corp / RXN FAQ

What is the fundamental rating for RXN stock?

ChartMill assigns a fundamental rating of 5 / 10 to RXN.


What is the valuation status of Rexnord Corp (RXN) stock?

ChartMill assigns a valuation rating of 0 / 10 to Rexnord Corp (RXN). This can be considered as Overvalued.


How profitable is Rexnord Corp (RXN) stock?

Rexnord Corp (RXN) has a profitability rating of 6 / 10.


How financially healthy is Rexnord Corp?

The financial health rating of Rexnord Corp (RXN) is 6 / 10.


What is the earnings growth outlook for Rexnord Corp?

The Earnings per Share (EPS) of Rexnord Corp (RXN) is expected to grow by 17.51% in the next year.